Dr. Christopher Leigh Hallemeier, MD

Dr. Hallemeier practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Hallemeier's NPI, 1134383417, was assigned on July 15, 2008. Dr. Hallemeier graduated from University Of Minnesota Medical School in 2008. Dr. Hallemeier holds Minnesota license 52237.

Dr. Hallemeier's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Hallemeier's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Hallemeier to 1 more hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hallemeier practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hallemeier's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hallemeier is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Hallemeier's licenses on file in 5 states: Minnesota, Iowa, Illinois, Michigan and Wisconsin.

Dmand AI lists anal cancer radiation, bone cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and pancreatic cancer radiation among the conditions Dr. Hallemeier treats.

CMS data shows 1,470 Medicare services from Dr. Hallemeier across 11 procedure codes in 2024, for 192 Medicare patients. Medicare paid $99,904 for them.

CMS counts 192 Medicare patients who saw Dr. Hallemeier in 2024. The largest group is 65 to 74, with 112 patients. 69% of them have high blood pressure, and 66% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hallemeier's median patient age at 72, with 41% women.

In 2024, Dr. Hallemeier wrote 24 Medicare Part D claims for 14 patients. 75% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $74 in total drug cost.

Dr. Hallemeier accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 162 papers to Dr. Hallemeier, published from 2006 to 2025. 2021 was the busiest year, with 18. The most frequent topics are Pancreatic Neoplasms, Neoadjuvant Therapy and Chemoradiotherapy. Dr. Hallemeier has published most often in Int J Radiat Oncol Biol Phys. Dr. Hallemeier's most frequent co-authors are Michael G. Haddock, MD, Kenneth Wing Merrell, MD and Krishan Ratilal Jethwa, MD.

Dmand AI links Dr. Hallemeier to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Carcinoma, Hepatocellular and Liver Neoplasms.

CMS Open Payments shows 3 general payments to Dr. Hallemeier from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $135.

Dr. Hallemeier graduated from University Of Minnesota Medical School in 2008.

Dr. Hallemeier is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.